Gene interactions and pathways from curated databases and text-mining

◀ Back to TNF

F2RL1 — TNF

Pathways - manually collected, often from reviews:

  • OpenBEL Selventa BEL large corpus: F2RL1 → TNF (increases)
    Evidence: Table 3 - Changes in expression of PARs in vascular endothelial cells and smooth muscle cells.

Text-mined interactions from Literome

Lang et al., Invest Ophthalmol Vis Sci 2003 : HCE-T expression of cytokines ( IL-6, IL-8, and TNFalpha ) in response to activation of PAR-1 and -2 was measured by quantitative RT-PCR and ELISA
Tae et al., Clin Chim Acta 2003 (Disease Models, Animal...) : The AELJ ( 100 mg/kg ) also significantly inhibited PAR2 agonists induced myeloperoxidase (MPO) activity and tumor necrosis factor (TNF)-alpha expression in paw tissue
Ebeling et al., J Allergy Clin Immunol 2005 (Inflammation...) : PAR-2ap administered with allergen increased TNF and IL-5 mRNA in lung tissue and IL-13 and TNF in bronchoalveolar lavage fluid
Ramachandran et al., Am J Physiol Lung Cell Mol Physiol 2007 : Flow cytometry for PAR1, PAR2, and PAR3 also demonstrated selective PAR2 upregulation in response to TNF-alpha and LPS ... Upregulation of PAR2 by TNF-alpha heightened HPBF responses to trypsin, while PAR4 induction enabled cathepsin-G mediated calcium signaling
Ritchie et al., Br J Pharmacol 2007 (Calcium Signaling...) : We investigated the effects of tumour necrosis factor-alpha (TNF-alpha) , interleukin-1beta (IL-1beta), trypsin and the PAR2 activating peptide, 2-furoyl ( 2f ) -LIGKV-OH on both mRNA and functional expression of PAR2 in human umbilical vein endothelial cells ( HUVECs )
Amiable et al., Bone 2009 (Bone Resorption...) : On OA osteoblasts, PAR-2 production was significantly increased by IL-1 beta, TNF-alpha and PGE ( 2 )
Saito et al., Hum Reprod 2011 (Endometriosis...) : Only TGF-ß1, but neither TNF-a nor IL-1ß, increased gene expression of PAR2
Zhang et al., Cell Physiol Biochem 2012 (MAP Kinase Signaling System) : Inhibition of PAR-2 activation reduced tryptase induced TNF-alpha , IL-6 and ROS production, and mitochondrial membrane potential loss in microglia